Chimerix Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and Chimerix (NASDAQ:CMRX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings. Insider and Institutional Ownership 74.3% of Lipella Pharmaceuticals […]

Chimerix (NASDAQ:CMRX – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday. A number of other brokerages also recently commented on CMRX. HC Wainwright restated a “buy” rating and issued a $11.00 target price on shares of […]

Chimerix (NASDAQ:CMRX – Get Free Report) posted its earnings results on Wednesday. The biopharmaceutical company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.04), Zacks reports. Chimerix had a negative return on equity of 39.62% and a negative net margin of 25,337.96%. During the same quarter last […]

Vance Wealth Inc. purchased a new position in Chimerix, Inc. (NASDAQ:CMRX – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 47,320 shares of the biopharmaceutical company’s stock, valued at approximately $46,000. A number of other large investors have also added to or reduced their stakes in the company. RA Capital Management L.P. […]

Half Yearly Report - 31 December 2023 Kazia Therapeutics Limited ...